Recalls for Fresenius Kabi USA

Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles
07/02/2013 Medical Recall

If present, the administration of glass particulate poses a potential safety risk to patients.

  • Company:
    Fresenius Kabi USA
Fresenius Kabi USA Issues Voluntary Nationwide Recall of Benztropine Mesylate Injection, USP 2 mg/2 mL (1 mg/mL), in 2 mL Single Dose Vials
07/01/2013 Food Recall

LAKE ZURICH, Ill. - Fresenius Kabi USA is voluntarily recalling four lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the potential presence of glass particles (glass delamination) in the vials. This recall is being conducted to the user level.

  • Company:
    Fresenius Kabi USA
  • Problem
    Undeclared Milk